This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Breast Cancer
and you are
over 25
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The hypothesis of this study is that positron emission mammography will provide comparable sensitivity to contrast-enhanced breast MRI in women with a high suspicion of breast cancer. The aim of this study is to determine the sensitivity of Positron Emission Mammography (PEM) relative to that of Contrast-enhanced breast MRI (CE-MRI) in women with a high suspicion of breast cancer

Provided treatments

  • Device: Breast PET
Tris trial is registered with FDA with number: NCT02770586. The sponsor of the trial is Mayo Clinic and it is looking for 150 volunteers for the current phase.
Official trial title:
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI in Women With a High Suspicion of Breast Cancer